BDX

SEC source: 0001628280-26-060580 · wk-form4_1788477895.xml · nonDerivative · entry 1

Roque Vitor · CIK 0002098881 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,041

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards

SEC source: 0001628280-26-059269 · wk-form4_1787862519.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,720

SEC source: 0001628280-26-058647 · wk-form4_1787602744.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,885

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards

SEC source: 0001628280-26-057166 · wk-form4_1786739778.xml · derivative · entry 4

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 43,278 shares

Expires 2027-11-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Award terms reflect the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

F2 · derivative.exercise_date: The stock appreciation rights vested in four annual installments beginning November 26, 2018.

SEC source: 0001628280-26-057166 · wk-form4_1786739778.xml · nonDerivative · entry 3

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,163

SEC source: 0001628280-26-057166 · wk-form4_1786739778.xml · nonDerivative · entry 2

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,315

SEC source: 0001628280-26-057166 · wk-form4_1786739778.xml · nonDerivative · entry 1

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 153,441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-056366 · wk-form4_1786570038.xml · nonDerivative · entry 1

Goette Roland · CIK 0001708067 · EVP and President, EMEA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,856

F1 · shares: Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP").

F2 · balance_after: Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

SEC source: 0001628280-26-054422 · wk-form4_1786049274.xml · derivative · entry 1

Huffines Robert Luther · CIK 0001728221 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 595

Underlying: Common Stock · 189 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-054418 · wk-form4_1786049218.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,810

Underlying: Common Stock · 94 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-049989 · wk-form4_1785251777.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,934

SEC source: 0001628280-26-047193 · wk-form4_1783365371.xml · nonDerivative · entry 2

Muhsin Bilal · CIK 0001734507 · EVP & President Connected Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,359

F3 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

SEC source: 0001628280-26-047193 · wk-form4_1783365371.xml · nonDerivative · entry 1

Muhsin Bilal · CIK 0001734507 · EVP & President Connected Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,294

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-045864 · wk-form4_1782521257.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,009

SEC source: 0001628280-26-045374 · wk-form4_1782396959.xml · nonDerivative · entry 1

Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,172

SEC source: 0001628280-26-042571 · wk-form4_1781212873.xml · nonDerivative · entry 1

Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,272

F1 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-039738 · wk-form4_1780423907.xml · nonDerivative · entry 1

Menziuso Peter · CIK 0002135899 · EVP and President, BDI

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,258

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001628280-26-040095 · wk-form4_1780505062.xml · derivative · entry 4

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,209 shares

Expires 2026-11-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Award terms reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

F3 · shares: Award terms reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.

F4 · derivative.exercise_date: The stock appreciation rights vested in four annual installments beginning November 26, 2017.

SEC source: 0001628280-26-040095 · wk-form4_1780505062.xml · nonDerivative · entry 3

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,163

F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $145.21 through $147.49. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-040095 · wk-form4_1780505062.xml · nonDerivative · entry 2

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,235

SEC source: 0001628280-26-040095 · wk-form4_1780505062.xml · nonDerivative · entry 1

Polen Thomas E Jr · CIK 0001621793 · Director · Chairman, CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-26-038382 · wk-form4_1779903672.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,084

SEC source: 0001628280-26-033027 · wk-form4_1778275604.xml · derivative · entry 1

Huffines Robert Luther · CIK 0001728221 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 404

Underlying: Common Stock · 210 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend investment since the last report filed by the reporting person.

F4 · balance_after: Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person.

SEC source: 0001628280-26-033022 · wk-form4_1778275502.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,699

Underlying: Common Stock · 105 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

F4 · balance_after: Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person.

SEC source: 0001628280-26-032999 · wk-form4_1778274279.xml · nonDerivative · entry 1

Roque Vitor · CIK 0002098881 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,231

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001628280-26-027731 · wk-form4_1777376656.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,159

SEC source: 0001628280-26-023944 · wk-form4_1775510928.xml · nonDerivative · entry 1

Neal Shana Carol · CIK 0001735118 · EVP and Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,966

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

F2 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-021644 · wk-form4_1774633795.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,233

F1 · balance_after: This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 7, 2025.

SEC source: 0001628280-26-018607 · wk-form4_1773773181.xml · nonDerivative · entry 1

Minnix Lanesha · CIK 0001708662 · EVP and General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,492

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

SEC source: 0001628280-26-014440 · wk-form4_1772642848.xml · nonDerivative · entry 1

Roque Vitor · CIK 0002098881 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,510

F1 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-014438 · wk-form4_1772642743.xml · nonDerivative · entry 1

Spikner Pamela L. · CIK 0002012329 · SVP Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,323

F1 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-012955 · wk-form4_1772232327.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,308

F1 · balance_after: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

SEC source: 0001628280-26-009242 · wk-form4_1771453248.xml · nonDerivative · entry 1

SCOTT BERTRAM L · CIK 0001221780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,763

SEC source: 0001628280-26-005700 · wk-form4_1770312252.xml · derivative · entry 1

Huffines Robert Luther · CIK 0001728221 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100

Underlying: Common Stock · 100 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

SEC source: 0001628280-26-005695 · wk-form4_1770312101.xml · derivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,714

Underlying: Common Stock · 30 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001628280-26-005690 · wk-form4_1770311892.xml · derivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,649

Underlying: Common Stock · 272 shares

Expires not disclosed

F1 · derivative.exercise_price: The securities convert to common stock on a one-for-one basis.

F2 · derivative.exercise_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F2 · derivative.expiration_date: The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person.

F3 · balance_after: Includes rights acquired through dividend reinvestment since the last report filed by the reporting person.

SEC source: 0001628280-26-004017 · wk-form4_1769698638.xml · nonDerivative · entry 1

ECKERT R ANDREW · CIK 0001210525 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,423

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004019 · wk-form4_1769698710.xml · nonDerivative · entry 1

Henderson Jeffrey William · CIK 0001324015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,143

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004015 · wk-form4_1769698563.xml · nonDerivative · entry 1

Byington Carrie L · CIK 0001890265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,018

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004010 · wk-form4_1769698358.xml · nonDerivative · entry 1

Brown William M · CIK 0001350633 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,663

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004013 · wk-form4_1769698476.xml · nonDerivative · entry 1

HAYES GREGORY · CIK 0001225946 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,159

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004008 · wk-form4_1769698237.xml · nonDerivative · entry 1

Huffines Robert Luther · CIK 0001728221 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,279

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004006 · wk-form4_1769698133.xml · nonDerivative · entry 1

Jones Christopher Ian Montague · CIK 0001292762 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,304

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004004 · wk-form4_1769698020.xml · nonDerivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,160

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-004002 · wk-form4_1769697927.xml · nonDerivative · entry 1

SCOTT BERTRAM L · CIK 0001221780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,716

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-003999 · wk-form4_1769697838.xml · nonDerivative · entry 1

Waldstreicher Joanne · CIK 0001962413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,391

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-003997 · wk-form4_1769697739.xml · nonDerivative · entry 1

Wright Jacqueline · CIK 0001806405 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,279

F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2 · balance_after: Includes units acquired through dividend investment since the last report filed by the reporting person.

SEC source: 0001628280-26-003734 · wk-form4_1769611611.xml · nonDerivative · entry 1

Feld Michael · CIK 0002034349 · EVP, CRO & Pres. Life Sciences

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,431

SEC source: 0002012329-26-000002 · wk-form4_1769179611.xml · nonDerivative · entry 1

Spikner Pamela L. · CIK 0002012329 · SVP Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,832

F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

SEC source: 0001944816-26-000002 · wk-form4_1768596224.xml · derivative · entry 5

Garrison Michael David · CIK 0001944816 · EVP & Pres Med.Essntl&BioPharm

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,054 shares

Expires 2026-11-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four annual installments beginning one year from the grant date.